Implementation of PMBJP

1. At a Glance

• PMBJP = Pradhan Mantri Bhartiya Janaushadhi Pariyojana — flagship scheme of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers to supply quality generic medicines at affordable prices via dedicated outlets called Jan Aushadhi Kendras (JAKs / PMBJKs) [1][2].
• Implementing agency: Pharmaceuticals & Medical Devices Bureau of India (PMBI) — an autonomous society under DoP [2].
• Salient for UPSC: intersection of health affordability, generic drugs policy, out-of-pocket expenditure (OOPE) reduction, MSME pharma, last-mile delivery.

2. Why in the News

• PIB (13 Feb 2026): Govt reported 17,990 JAKs operational as on 31.12.2025 and reaffirmed target of 25,000 JAKs by March 2027 [1].
• New incentive (since Sept 2024) to JAK owners for stocking 200 commonly used medicines (100 top-selling in scheme + 100 fast-moving in market) — to address supply gaps [1].

3. Background & Evolution

• Launched 2008 as Jan Aushadhi Campaign by Dept. of Pharmaceuticals; relaunched/renamed PMBJP in 2015–16 with expanded scope [2].
• 2019: Re-christened with current branding "Pradhan Mantri Bhartiya Janaushadhi Pariyojana"; coverage of districts widened [2].
• Dec 2023: First time crossed ₹1,000 Cr annual sales (FY 2023-24) [3].
• Oct 2024: Crossed ₹1,000 Cr sales within seven months of FY 2024-25 [3].
• 28 Feb 2025: 15,000 JAKs opened; FY24-25 sales ₹1,760 Cr (MRP) [3].
• 31 Dec 2025: 17,990 JAKs [1].

4. Core Static Facts

• Parent Ministry: Ministry of Chemicals & Fertilizers → Department of Pharmaceuticals [1].
• Implementing body: PMBI (Pharmaceuticals & Medical Devices Bureau of India), autonomous society [2].
• Product basket: 2,425 items — medicines + surgicals/consumables; covers cardiovascular, oncology, anti-diabetic, anti-infectives, anti-allergic, GI [2].
• Pricing: 50%–80% cheaper than branded equivalents [2].
• Quality control: Samples drawn from 100% of batches; testing only at NABL-accredited labs; supply only after pass [2].
• Outlet count: 17,990 JAKs (31.12.2025); target 25,000 by March 2027 [1].
• Sales: ₹1,000 Cr in FY 2023-24; ₹1,760 Cr by 28.02.2025 in FY24-25 [3][4].
• Jan Aushadhi Diwas: observed 7 March annually (7th edition in 2025) [4].

5. Multi-Dimensional Analysis

Economic

• Reduces household OOPE on medicines (~~50% of total OOPE on health in India); ₹1,760 Cr MRP sales (FY24-25 partial) translates to multi-thousand-crore consumer savings via 50-80% price gap [2][3].
• Creates self-employment for JAK owners (pharmacists, NGOs, SHGs, individuals) via margin + incentives [1].

Social

• Targets equity in access to essential medicines for poor/middle-class; relevant to SDG 3 (UHC).
• 200-medicine stocking incentive (Sept 2024) addresses stock-out grievances at rural JAKs [1].

Administrative / Implementation

• District saturation drive — earlier 743/766 districts covered; now nationwide footprint with state-wise/UT-wise annexure published [1][5].
• Bottlenecks: stock-outs, low margins on non-fast-movers, last-mile logistics — addressed via PMBI's CFA-based supply chain and new monthly incentive [1].

Governance / Quality

• 100% batch testing in NABL-accredited labs distinguishes PMBJP generics from "branded generics" — answers the common quality-doubt critique [2].

Scientific / Pharma policy

• Promotes unbranded generic prescription — aligned with NMC's directions and Essential Medicines List logic.

6. Recent Developments (last 12-18 months)

• Sept 2024: Monthly incentive scheme for JAKs stocking 200 fast-moving medicines introduced [1].
• Oct 2024: ₹1,000 Cr sales achieved in 7 months of FY24-25 [3].
• 1–7 March 2025: 7th Jan Aushadhi Diwas — theme "जन औषधि: दाम कम, दवाई उत्तम"; Jan Aushadhi Jan Chetna Abhiyan across districts; flagged off by Union Minister J.P. Nadda [4].
• Feb 2025 (Mahakumbh, Prayagraj): JAKs deployed for pilgrim drug access [4].
• 31 Dec 2025: 17,990 JAKs operational [1].

7. Prelims Hooks

• PMBJP is implemented by PMBI under Dept. of Pharmaceuticals, Min. of Chemicals & Fertilizers — NOT Min. of Health [1][2].
• Outlets are called Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJK) / Jan Aushadhi Kendras [2].
• Jan Aushadhi Diwas: 7 March every year [4].
• Product basket size: 2,425 (medicines + surgicals/consumables) [2].
• Price discount: 50%–80% below branded medicines [2].
• 17,990 JAKs as on 31.12.2025; target 25,000 by March 2027 [1].
• Quality testing at NABL-accredited labs, 100% of batches [2].
• Scheme launched 2008; re-launched as PMBJP 2015-16 [2].
• FY 2023-24 sales: ₹1,000 Cr (first time) [3].
• Incentive for stocking 200 medicines (100 top-selling + 100 fast-moving) introduced September 2024 [1].
• Union Minister (C&F + H&FW) overseeing as of 2025: J.P. Nadda [4].

8. Mains Relevance

• GS-II: Government policies & interventions in Health Sector; Issues relating to development & management of Social Sector — Health.
• GS-III: Indian Economy — inclusive growth; Pharma sector / MSME linkage.
• Possible stems: 1. "PMBJP has emerged as a pillar of affordable healthcare but its impact remains uneven. Examine." 2. "Discuss the role of generic medicines in reducing out-of-pocket expenditure on health in India with reference to PMBJP." 3. "Quality, last-mile availability, and prescriber behaviour are the three challenges of Jan Aushadhi. Critically analyse."

9. Related Topics to Study Next

• Ayushman Bharat – PMJAY — complementary affordability pillar.
• National Health Policy 2017 — UHC framework hosting PMBJP.
• Drugs (Prices Control) Order (DPCO) & NPPA — pricing of essential medicines.
• National List of Essential Medicines (NLEM) — overlap with JAK basket.
• Pharma sector PLI Scheme & Bulk Drug Parks — supply-side for APIs feeding PMBJP.
• Out-of-Pocket Expenditure / National Health Accounts — context for affordability metric.
• PM-ABHIM & Health Infra Mission — last-mile delivery synergies.
• Generic vs Branded-Generic vs Branded drug debate — NMC prescribing guidelines.

10. Common Errors / Trap Areas

• Wrong ministry: It is Chemicals & Fertilizers, not Health & Family Welfare.
• Wrong implementing agency: PMBI (autonomous society), not CDSCO / NPPA / CPSE.
• Launch year confusion: Scheme (Jan Aushadhi) 2008; rebranded/expanded PMBJP 2015-16 — not 2008 as PMBJP.
• Basket size: 2,425 items (medicines + surgicals); not "essential medicines list = 384".
• Jan Aushadhi Diwas date: 7 March (not Mar 1 — that's the week's start).
• Distinguish PMBJP generics (100% batch-tested at NABL labs) from "branded generics" sold by private pharmacies.